Emilio Gonzalez

View Scopus Profile

Emailebgonzalutmbedu

h-index

Research activity per year

If you made any changes in Pure these will be visible here soon.

Research interests

ITS
Translational Science

Research Strategic Pillar Keywords

Infectious/ Immunological Health

Fingerprint

Dive into the research topics where Emilio Gonzalez is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

29 Completed

Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"
Gonzalez, E.
3/6/17 → 3/5/19
Project: Other project
Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"
Gonzalez, E.
3/6/17 → 3/5/19
Project: Other project
Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"
Gonzalez, E.
Inventiv Health Clinical
3/6/17 → 3/5/19
Project: Other project
Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)
Gonzalez, E.
8/26/14 → 8/25/16
Project: Other project
Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)
Gonzalez, E.
8/26/14 → 8/25/16
Project: Other project

61 Article
10 Review article
7 Letter
4 Comment/debate
More
- 1 Chapter

Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review
Gonzalez, D., Gupta, L., Murthy, V., Gonzalez, E. B., Williamson, K. A., Makol, A., Tan, C. L., Sulaiman, F. N., Shahril, N. S., Isa, L. M., Martín-Nares, E. & Aggarwal, R., Sep 2022, In: Rheumatology International. 42, 9, p. 1629-1641 13 p.
Research output: Contribution to journal › Review article › peer-review

Open Access
4 Scopus citations
Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry
APS ACTION Investigators, Oct 2022, In: Lupus. 29, 11, p. 1353-1363 11 p.
Research output: Contribution to journal › Article › peer-review
18 Scopus citations
PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome
Willis, R., McDonnell, T. C. R., Pericleous, C., Gonzalez, E. B., Schleh, A., Romay-Penabad, Z., Giles, I. P. & Rahman, A., Apr 11 2022, In: Frontiers in immunology. 13, 842923.
Research output: Contribution to journal › Article › peer-review

Open Access
Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria
the New APS Classification Criteria Collaborators, Oct 2021, In: Arthritis Care and Research. 73, 10, p. 1490-1501 12 p.
Research output: Contribution to journal › Article › peer-review
22 Scopus citations
Non-Healing Leg Ulcers in a Patient with Rheumatoid Arthritis
Sood, A., Gonzalez, D., Sonkar, J., Murthy, V. & Gonzalez, E., Oct 2021, In: American Journal of Medicine. 134, 10, p. e522-e523
Research output: Contribution to journal › Article › peer-review

Emilio Gonzalez, MD

Personal profile

Research interests

Research Strategic Pillar Keywords

Fingerprint

Network

Dive into details

Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"

Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"

Protocol N1071F2: "A Randomized, Double-Blind, Multicenter, 3 Stage, Efficacy and Safety Study of NI-071 and US-Licensed Remicade (Infliximab) for the Treatment of Patients with Rheumatoid Arthritis"

Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)

Protocol EMR700461-024: A Phase IIB, Multi-Center, Long-Term Extension Trial to Evaluate the Safety and Tolerability of Atacicept in Subjects with Systemic Lupus Erythematosus (SLE) who Completed Protocol EMR-700461-023 (ADDRESS II)

Anti-MDA5 dermatomyositis after COVID-19 vaccination: a case-based review

Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry

PEGylated Domain I of Beta-2-Glycoprotein I Inhibits Thrombosis in a Chronic Mouse Model of the Antiphospholipid Syndrome

Development of a New International Antiphospholipid Syndrome Classification Criteria Phase I/II Report: Generation and Reduction of Candidate Criteria

Non-Healing Leg Ulcers in a Patient with Rheumatoid Arthritis

Emilio Gonzalez, MD

Personal profile

Research interests

Research Strategic Pillar Keywords

Fingerprint

Network

Projects

Research output